S'abonner

What Women Want: Radical Cystectomy and Perioperative Sexual Function Educational Needs - 09/12/21

Doi : 10.1016/j.urology.2021.06.012 
Mary E. Westerman 1, Kelly K. Bree 1, Andrea Kokorovic 1, Jane Frank 2, Xin Shelly Wang 3, Ashish M. Kamat 1, Colin P.N. Dinney 1, Neema Navai 1,
1 Department of Urology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 
2 Office of Patient Education, The University of Texas, M.D. Anderson Cancer Center 
3 Department of Symptom Research, The University of Texas, M.D. Anderson Cancer Center 

Address correspondence to: Neema Navai, M.D., nnavai@mdanderson.org. Department of Urology, 1515 Holcombe – Unit 1373, Houston, TX 77030Department of Urology1515 Holcombe – Unit 1373HoustonTX77030

HIGHLIGHTS

Treatment of muscle invasive and high-risk non-muscle invasive bladder cancer can have significant impact on sexual function (SF) in female patients.
Many women report receiving inadequate pre-operative counseling surrounding sexual health issues.
Among survey respondents, vaginal preservation was important, and dyspareunia was the most common post-operative change in sexual function.
Most women preferred provider-initiated pre-operative counseling surrounding sexual health, but also requested printed material to refer to later and/or share with partners.

Le texte complet de cet article est disponible en PDF.

Abstract

Objective

To assess the extent and adequacy of pre-operative sexual function (SF) counseling in females undergoing radical cystectomy (RC) and develop educational material to improve identified deficits.

Methods

A 10-question survey was electronically delivered to all females who underwent RC at a single institution between 2015 and 2020. 23 of 145 patients responded (15.9%). In addition, women on the Bladder Cancer Advocacy Network (BCAN) patient discussion board were also queried. The primary outcome was the development of a patient educational handout based on patient perception of pre-operative SF counseling and self-reported changes in post-operative SF.

Results

22 women, 84% of whom were sexually active, met the inclusion criteria. More than half (12/22, 54.5%) reported receiving no pre-operative counseling regarding possible SF changes while another 27.3% (6/22) received some counseling but desired more. Most women rated vaginal preservation as moderate to very important (17/22, 77.3%) and nearly all women noted at least one change in SF, most commonly dyspareunia (13/22, 59.1%). Most also desired more information regarding female sexual health. Separately, the BCAN discussion board was queried regarding patient preference for modality of pre-operative counseling. 77.8% (14/18) preferred a discussion with provider and 13/18 (72.2%) also wanted a written handout.

Conclusions

Sexual dysfunction is prevalent following RC in women and many desire more pre-operative counseling, regardless of disease stage or receipt of chemotherapy. These findings supported our development of interventions to improve pre-operative education as well as strategies to address post-operative SF changes, such as dyspareunia.

Le texte complet de cet article est disponible en PDF.

Mots-clés : Abbreviations: BCa, BCAN, FSFI, MDACC, QoL, RC, SF


Plan


 Funding: This study was supported by an R01 grant from the NIH administered by NCI (Principal Investigators: Xin Shelly Wang MD, MPH; Grant # 5R01CA205146-04).


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 157

P. 181-187 - novembre 2021 Retour au numéro
Article précédent Article précédent
  • Functional and Oncological Outcomes of Renal Surgery for Hilar Tumors: Informing the Decisions in Risk-Adapted Management
  • Ricardo G. Alvim, Amy L. Tin, Lucas Nogueira, Nathan C. Wong, Renato C. Fonseca, Daniel D. Sjoberg, A. Ari Hakimi, Karim A. Touijer, Paul Russo, Jonathan A. Coleman
| Article suivant Article suivant
  • When is a Seminoma not a Seminoma? The Incidence, Risk Factors and Management of Patients With Testicular Seminoma With Discordant Elevated Serum Alpha-fetoprotein
  • Katherine E. Fero, Patrick M. Lec, Vidit Sharma, Andrew T. Lenis, Josiah Low, Mark S. Litwin, Michael S. Leapman, Karim Chamie

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.